Constellation Brands and Caribou Biosciences Shares Decline in U.S. Pre-Market Trading

Key Facts

1Constellation Brands shares dropped 5.1% in pre-market trading despite beating earnings estimates.

2Biotech and mining stocks, including Caribou Biosciences, saw declines during Wednesday's pre-market session.

Constellation Brands shares dropped 5.1% in pre-market trading on Wednesday despite the company's earnings results beating estimates. Benzinga reported that biotech and mining stocks, including Caribou Biosciences, saw collective declines during the pre-market session as broader stock futures trended lower.

STZ closed at $115.67 on October 6, 2026, while CRBU closed at $1.14 on the same date. The downward movement follows a shift in market sentiment that weighed on multiple sectors, suggesting a potential 'sell the news' reaction or concerns regarding underlying details within the earnings reports.